World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 29 March 2021
Main ID:  ACTRN12614000641695
Date of registration: 18/06/2014
Prospective Registration: No
Primary sponsor: University of Malaya
Public title: An interventional study on physicians’ adherence to hypertension guidelines
Scientific title: Effect of a complex intervention involving primary care doctors on blood pressure control in patients with hypertension
Date of first enrolment: 07/10/2013
Target sample size: 570
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12614000641695.aspx
Study type:  Interventional
Study design:  Purpose: Prevention; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Malaysia
Contacts
Name: Prof Ee Ming Khoo   
Address:  Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Jalan Lembah Pantai 50603, Kuala Lumpur, Malaysia
Telephone: +603 79492306
Email: khooem@um.edu.my
Affiliation: 
Name: Prof Ee Ming Khoo   
Address:  Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Jalan Lembah Pantai 50603, Kuala Lumpur, Malaysia
Telephone: +603 79492306
Email: khooem@um.edu.my
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: All primary care physician working at the Primary Care Clinic at the University Malaya Medical Centre (UMMC) who are treating the cohort of patients with hypertension from earlier phase of this study (patient with hypertension for at least a year and have been followed up at the Primary Care Clinic).

Earlier phase of the study is a retrospective review of records and it is not registered as it is not an intervention trial. We have published a paper from earlier phase of the study :

Liew et al.: Statins use is associated with poorer
glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes. Diabetology & Metabolic Syndrome 2014 6:53. doi:10.1186/1758-5996-6-53

Exclusion criteria: All primary care physician working at the Primary Care Clinic at the University Malaya Medical Centre (UMMC) who are not treating the cohort of patients with hypertension from earlier phase of the study

Age minimum: No limit
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Public Health - Health service research
Cardiovascular - Hypertension
Hypertension;
Hypertension
Intervention(s)
This is a before-and-after study using clinical support tools and health care professional training. Assessments are done at 0-3 months post intervention for immediate effect of intervention and 3-6 months post interventions for sustainability of intervention.

The intervention package consists of :

1. A training session conducted by senior academicians to modify the primary care physicians' practice according to guidelines recommendations pre intervention

2. A quick reference guide summarising recommendations from the guideline to put on desktops as well as online on computers of each consultation room for easy access and reference for doctors throughout the study duration

3. At patient's first visit:
(i) Patients have to fill self assessment forms prior to consultation with doctor
(ii) Patients' anthropometric parameters (weight, height and waist circumference) are measured by nurses
(iii) A personalized checklist for the doctors is placed in the patient's medical record to be utilized as a quick reference and reminder to the doctor on the essential parameters that are required for evaluation. The checklist includes documentation of cardiovascular risk factors and comorbidities, secondary causes, investigations ordered, target organ damage, patient's estimated cardiovascular risk, medications, BP measurement and physcical examination findings.
(iv) Sets of investigations forms are placed in the medical records as reminder for doctors and for ease of administration

4. At patients' follow up visits at 3 to 6 months, a checklist is placed in the medical records that includes documentation of weight, blood pressure, investigations ordered, medications, presence of target organ damage and complications.
Primary Outcome(s)
Primary outcome is the proportion of patients with controlled blood pressure. Controlled blood pressure is defined as blood pressure less than 140/90mmHg and measured using mercury sphygmomanometer by the doctors.
[0 to 3 months post intervention for immediate effect of intervention, 3 to 6 months post intervention for sustainability of intervention]
Secondary Outcome(s)
The rates of documentation of process indicators and outcome indicators from the checklist provided in the medical records: these include the rate of documentation of process indicators (BP, weight measurement, assessment of cardiovascular risk factors, target organ damage and comorbidities, examinations, investigatory tests ordered) and the rate of documentation of outcome indicators (medication use) [0 to 3 months post intervention for immediate effect of intervention, 3 to 6 months post intervention for sustainability of intervention]
Secondary ID(s)
Nil known
Source(s) of Monetary Support
University Malaya Research Grant (UMRG) 513- 13 HTM, Institute of Research Management and Monitoring (IPPP), University of Malaya, Malaysia
University Malaya Research Grant (UMRG) 315- 11 HTM, Institute of Research Management and Monitoring (IPPP), University of Malaya, Malaysia
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 23/11/2011
Contact:
Medical Ethics Committee, University Malaya Medical Centre (UMMC)
Results
Results available: Yes
Date Posted: 19/03/2021
Date Completed: 15/05/2014
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history